Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,439 | -5,101 | -45,738 | -36,206 | -19,670 |
| Depreciation Amortization | 1,428 | 845 | 2,459 | 1,850 | 1,242 |
| Accounts receivable | N/A | N/A | -1,813 | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | 7,049 | N/A | N/A |
| Other Working Capital | -26,938 | -19,651 | 30,525 | 33,789 | 33,733 |
| Other Operating Activity | 2,728 | 1,264 | -142 | 3,851 | 2,463 |
| Operating Cash Flow | $-38,221 | $-22,643 | $-7,660 | $3,284 | $17,768 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,018 | -389 | -949 | -607 | -257 |
| Purchase Of Investment | -31,645 | -16,559 | N/A | N/A | N/A |
| Sale Of Investment | 4,850 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-27,813 | $-16,948 | $-949 | $-607 | $-257 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,839 | 6,558 | 59,127 | 54,226 | 32,310 |
| Financing Cash Flow | $6,839 | $6,558 | $59,127 | $54,226 | $32,310 |
| Exchange Rate Effect | -4,312 | -994 | -3,190 | -2,287 | -1,160 |
| Beginning Cash Position | 117,764 | 117,764 | 70,436 | 70,436 | 70,436 |
| End Cash Position | 54,257 | 83,737 | 117,764 | 125,052 | 119,097 |
| Net Cash Flow | $-63,507 | $-34,027 | $47,328 | $54,616 | $48,661 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,221 | -22,643 | -7,660 | 3,284 | 17,768 |
| Capital Expenditure | -1,018 | -389 | -949 | -607 | -257 |
| Free Cash Flow | -39,239 | -23,032 | -8,609 | 2,677 | 17,511 |